7. Exploring the frontiers of Virtual and Augmented Reality
Posted: Sun Jan 12, 2025 5:09 am
In the pharmaceutical sector, in particular, we must start from the “physical world”, that of general practitioners, pharmacies and parapharmacies, to arrive at the “digital world”. But we must also be aware of the fact that the digital world is increasingly composite , and is made up of computers, but also increasingly of smartphones and tablets, of dedicated applications to download and of more or less generalist social networks.
The perspective to adopt, in short, is that of omnichannel : optimizing your campaigns (marketing or customer care) based on different devices and different channels. Where to start? Certainly from mobile.
Just think about these data: today, in the world, a good 91% of users access the azerbaijan phone data Internet via mobile and smartphone owners, across the planet, are approximately 4 billion (source: hdblog.com).
According to the latest studies, by 2024 the Virtual Reality software market is expected to grow to reach a value of 12 billion dollars, from 2.6 billion dollars in 2020 : we are talking about exponential growth (source: backtowork24.com).
This growth is evidence that VR (Virtual Reality) and AR (Augmented Reality) systems are increasingly entering our daily lives. The most innovative companies have noticed this for some time, and are already putting the first marketing strategies into action that are based precisely on these new systems, with enormous potential. This is also happening in the pharmaceutical sector.
Novartis , for example, has recently entered into a partnership with Microsoft and has begun producing Virtual Reality systems, with the aim of showing patients (in 3D and 360-degree mode) the interaction of drug molecules with their own body tissues. The aim is to explain in an incisive, engaging and very transparent way how drugs work.
We are only at the beginning of this further revolution, which can be very promising indeed. But it will only strengthen the assumption from which the best marketing strategies for the pharmaceutical sector start: everything must revolve around people, around patients.
The perspective to adopt, in short, is that of omnichannel : optimizing your campaigns (marketing or customer care) based on different devices and different channels. Where to start? Certainly from mobile.
Just think about these data: today, in the world, a good 91% of users access the azerbaijan phone data Internet via mobile and smartphone owners, across the planet, are approximately 4 billion (source: hdblog.com).
According to the latest studies, by 2024 the Virtual Reality software market is expected to grow to reach a value of 12 billion dollars, from 2.6 billion dollars in 2020 : we are talking about exponential growth (source: backtowork24.com).
This growth is evidence that VR (Virtual Reality) and AR (Augmented Reality) systems are increasingly entering our daily lives. The most innovative companies have noticed this for some time, and are already putting the first marketing strategies into action that are based precisely on these new systems, with enormous potential. This is also happening in the pharmaceutical sector.
Novartis , for example, has recently entered into a partnership with Microsoft and has begun producing Virtual Reality systems, with the aim of showing patients (in 3D and 360-degree mode) the interaction of drug molecules with their own body tissues. The aim is to explain in an incisive, engaging and very transparent way how drugs work.
We are only at the beginning of this further revolution, which can be very promising indeed. But it will only strengthen the assumption from which the best marketing strategies for the pharmaceutical sector start: everything must revolve around people, around patients.